Apotex, Inc. - Strategy, SWOT and Corporate Finance Report

Products Id :- A35FA664-3CF1-4829-A437-C15A37209D31
|
Pages: 38
|
August 2018
|
Region: North America
|

Request for Sample Report

Request A Quote

Executive Summary

Apotex, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Apotex, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Apotex, Inc. (Apotex or 'the company') is a privately-owned generic pharmaceutical company with operations in Canada. It is primarily involved in the research, development, manufacture and distribution of generic prescription drugs, fine chemicals and disposable plastics and non-prescription and private label medicines. These products cater to the needs of patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. The company operates and manages these business operations through its subsidiaries and research and development centers located worldwide. Apotex is headquartered in Ontario, Canada.

Scope

- Detailed information on Apotex, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Apotex, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Apotex, Inc. including a breakdown and examination of key business segments

- Intelligence on Apotex, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Apotex, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Apotex, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Apotex, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Apotex, Inc.'s business structure, strategy and prospects.

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249

Table of Contents

Company Snapshot 2

Table of Contents 5

Apotex, Inc.: Company Overview 9

Apotex, Inc.: Overview and Key Facts 9

Apotex, Inc.: Overview 9

Apotex, Inc.: Key Facts 9

Apotex, Inc.: Key Employees 10

Apotex, Inc.: Key Employee Biographies 11

Apotex, Inc.: Major Products and Services 12

Apotex, Inc.: Company History 13

Apotex, Inc.: Management Statement 16

Apotex, Inc.: Locations and Subsidiaries 17

Apotex, Inc.: Key Competitors 18

Apotex, Inc.: Company Analysis 19

Apotex, Inc.: Business Description 19

Apotex, Inc.: SWOT Analysis 20

Apotex, Inc.: SWOT Overview 20

Apotex, Inc.: Strengths 20

Apotex, Inc.: Weaknesses 21

Apotex, Inc.: Opportunities 21

Apotex, Inc.: Threats 22

Apotex, Inc.: Corporate Financial Deals Activity 23

Apotex, Inc.: Financial Deals Overview 23

Apotex, Inc.: Targets and Partners 25

Apotex, Inc.: Top Deals 2014-2018YTD 26

Apotex, Inc.: Advisors 27

Apotex, Inc.: Top Financial Advisors 27

Apotex, Inc.: Partnership 28

Apotex, Inc.: Divestments 29

Apotex, Inc.: Recent Developments 30

Apotex, Inc.: News and Events Summary 30

Apotex, Inc.: Business Expansion 32

Apotex, Inc.: Business Reorganization 32

Apotex, Inc.: Contracts 33

Apotex, Inc.: Corporate Governance 34

Apotex, Inc.: Financial Performance 34

Apotex, Inc.: Regulatory and Legal Events 35

Apotex, Inc.: Strategy and Operations 35

Appendix 36

Methodology 36

About MarketLine 37

List of Figures

Figure 1: Apotex, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Apotex, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Apotex, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 4: Apotex, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Figure 5: Apotex, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

List of Tables

Table 1: Apotex, Inc.: Key Facts

Table 2: Apotex, Inc.: Key Employees

Table 3: Apotex, Inc.: Locations and Subsidiaries

Table 4: Apotex, Inc.: Key Competitors

Table 5: Apotex, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: Apotex, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Apotex, Inc.: Targets and Partners

Table 8: Apotex, Inc.: Top Deals 2014-2018YTD

Table 9: Apotex, Inc.: Financial Advisor Ranking by Value (USD m)

Table 10: Apotex, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Table 11: Apotex, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Table 12: Apotex, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

Table 13: Apotex, Inc.: News and Events Summary

Table 14: Apotex, Inc.: Business Expansion

Table 15: Apotex, Inc.: Business Reorganization

Table 16: Apotex, Inc.: Contracts

Table 17: Apotex, Inc.: Corporate Governance

Table 18: Apotex, Inc.: Financial Performance

Table 19: Apotex, Inc.: Regulatory and Legal Events

Table 20: Apotex, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Apotex, Inc. - Strategy, SWOT and Corporate Finance Report

The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"

Wish to Know more

download

For Further Enquiry

apply for job

Know how We Roll

Engage with Us